Functional expression and purification of the untagged C-terminal domain of MMP-2 from Escherichia coli inclusion bodies

被引:1
作者
Zhou, Yi [1 ]
He, Chunmao [1 ]
机构
[1] South China Univ Technol, Sch Chem & Chem Engn, Guangzhou 510640, Peoples R China
基金
中国国家自然科学基金;
关键词
Matrix metalloproteinase 2; C-terminal domain; Expression and purification; Inclusion body; HUMAN GELATINASE-A; MATRIX-METALLOPROTEINASE; TISSUE INHIBITOR; IV COLLAGENASE; BINDING; ACTIVATION; CANCER; TIMP-2; FIBRONECTIN; COMPLEX;
D O I
10.1016/j.pep.2020.105726
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The C-terminal domain (CTD) of MMP-2, which includes a hemopexin-like domain, has been increasingly studied as an alternative target in developing selective intervention strategies towards MMP-2. Moreover, The CTD itself has been implicated in a growing number of biological events, either MMP-dependent or -independent. The production of CTD, however, has been mostly based on the uncontrolled lysis of the latent ProMMP-2 or fusion protein expression that leaves a fusion tag. In this work we present a facile production of the untagged CTD in E. coli. The target protein was expressed as inclusion bodies, and we established an efficient wash and refolding strategy that allows us to obtain the target protein in extremely high purity. The yield was established at similar to 6 mg/L of the culture medium, which would greatly facilitate the production and hence the biological study of CTD. The method described herein might also prove useful for related (domain) proteins in MMP family and beyond.
引用
收藏
页数:6
相关论文
共 26 条
  • [1] Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity
    Brooks, PC
    Silletti, S
    von Schalscha, TL
    Friedlander, M
    Cheresh, DA
    [J]. CELL, 1998, 92 (03) : 391 - 400
  • [2] Formation of the Complex of Nitrite with the Ferriheme b β-Barrel Proteins Nitrophorin 4 and Nitrophorin 7
    He, Chunmao
    Ogata, Hideaki
    Knipp, Markus
    [J]. BIOCHEMISTRY, 2010, 49 (28) : 5841 - 5851
  • [3] Matrix metalloproteinase-2: Not (just) a "hero" of the past
    Henriet, Patrick
    Emonard, Herve
    [J]. BIOCHIMIE, 2019, 166 : 223 - 232
  • [4] HOWARD EW, 1991, J BIOL CHEM, V266, P17972
  • [5] HOWARD EW, 1991, J BIOL CHEM, V266, P13064
  • [6] VMD: Visual molecular dynamics
    Humphrey, W
    Dalke, A
    Schulten, K
    [J]. JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 1996, 14 (01) : 33 - 38
  • [7] Overexpression in Escherichia coli and functional reconstitution of the liposome binding ferriheme protein nitrophorin 7 from the bloodsucking bug Rhodnius prolixus
    Knipp, Markus
    Zhang, Hongjun
    Berry, Robert E.
    Walker, F. Ann
    [J]. PROTEIN EXPRESSION AND PURIFICATION, 2007, 54 (01) : 183 - 191
  • [8] Structure of human pro-matrix metalloproteinase-2: Activation mechanism revealed
    Morgunova, E
    Tuuttila, A
    Bergmann, U
    Isupov, M
    Lindqvist, Y
    Schneider, G
    Tryggvason, K
    [J]. SCIENCE, 1999, 284 (5420) : 1667 - 1670
  • [9] Dissecting the role of matrix metalloproteinases (MMP) and integrin αvβ3 in anglogenesis In vitro:: Absence of hemopexin c domain bioactivity, but membrane-type 1-MMP and αvβ3 are critical
    Nisato, RE
    Hosseini, G
    Sirrenberg, C
    Butler, GS
    Crabbe, T
    Docherty, AJP
    Wiesner, M
    Murphy, G
    Overall, CM
    Goodman, SL
    Pepper, MS
    [J]. CANCER RESEARCH, 2005, 65 (20) : 9377 - 9387
  • [10] Tumour microenvironment - Opinion - Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
    Overall, CM
    Kleifeld, O
    [J]. NATURE REVIEWS CANCER, 2006, 6 (03) : 227 - 239